X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Elder Pharma with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs NATCO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA NATCO PHARMA ELDER PHARMA/
NATCO PHARMA
 
P/E (TTM) x -0.2 19.9 - View Chart
P/BV x 0.1 19.0 0.5% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 ELDER PHARMA   NATCO PHARMA
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
NATCO PHARMA
Mar-14
ELDER PHARMA/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs380877 43.3%   
Low Rs188424 44.4%   
Sales per share (Unadj.) Rs491.2223.4 219.8%  
Earnings per share (Unadj.) Rs-3.231.1 -10.2%  
Cash flow per share (Unadj.) Rs14.440.3 35.8%  
Dividends per share (Unadj.) Rs05.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs376.5219.5 171.5%  
Shares outstanding (eoy) m20.5433.07 62.1%   
Bonus/Rights/Conversions -PA-  
Price / Sales ratio x0.62.9 19.9%   
Avg P/E ratio x-89.320.9 -426.5%  
P/CF ratio (eoy) x19.716.1 122.1%  
Price / Book Value ratio x0.83.0 25.5%  
Dividend payout %016.1 0.0%   
Avg Mkt Cap Rs m5,83321,504 27.1%   
No. of employees `000NANA-   
Total wages/salary Rs m2,1791,128 193.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m10,0897,389 136.5%  
Other income Rs m257167 153.6%   
Total revenues Rs m10,3467,556 136.9%   
Gross profit Rs m-7921,793 -44.2%  
Depreciation Rs m361304 118.7%   
Interest Rs m2,756366 752.7%   
Profit before tax Rs m-3,6531,290 -283.2%   
Minority Interest Rs m046 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m125309 40.5%   
Profit after tax Rs m-651,027 -6.4%  
Gross profit margin %-7.824.3 -32.3%  
Effective tax rate %-3.423.9 -14.3%   
Net profit margin %-0.613.9 -4.7%  
BALANCE SHEET DATA
Current assets Rs m9,2403,681 251.0%   
Current liabilities Rs m9,9983,123 320.2%   
Net working cap to sales %-7.57.6 -99.3%  
Current ratio x0.91.2 78.4%  
Inventory Days Days4689 51.8%  
Debtors Days Days6059 102.1%  
Net fixed assets Rs m10,1247,685 131.7%   
Share capital Rs m206331 62.2%   
"Free" reserves Rs m5,5826,670 83.7%   
Net worth Rs m7,7347,259 106.5%   
Long term debt Rs m4,889955 512.0%   
Total assets Rs m22,88211,957 191.4%  
Interest coverage x-0.34.5 -7.2%   
Debt to equity ratio x0.60.1 480.6%  
Sales to assets ratio x0.40.6 71.4%   
Return on assets %11.811.7 100.9%  
Return on equity %-0.814.2 -6.0%  
Return on capital %22.320.7 107.6%  
Exports to sales %3.039.4 7.7%   
Imports to sales %0.45.7 7.5%   
Exports (fob) Rs m3072,908 10.5%   
Imports (cif) Rs m43421 10.2%   
Fx inflow Rs m3073,445 8.9%   
Fx outflow Rs m125703 17.8%   
Net fx Rs m1812,743 6.6%   
CASH FLOW
From Operations Rs m11,7541,440 816.1%  
From Investments Rs m-561-1,089 51.5%  
From Financial Activity Rs m-6,762-353 1,917.2%  
Net Cashflow Rs m4,432-1 -297,429.5%  

Share Holding

Indian Promoters % 39.6 52.0 76.1%  
Foreign collaborators % 0.0 1.5 -  
Indian inst/Mut Fund % 7.5 7.8 95.7%  
FIIs % 16.8 16.6 101.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 26.0 138.8%  
Shareholders   16,479 25,395 64.9%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   SHASUN PHARMA  WYETH LTD  ABBOTT INDIA  ALEMBIC LTD  DR. REDDYS LAB  

Compare ELDER PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Lower; Metal & Realty Stocks Fall(Closing)

Indian share markets ended lower today amid weak global cues. At the closing bell, the BSE Sensex finished lower by 262 points.

Related Views on News

NATCO PHARMA Announces Quarterly Results (4QFY18); Net Profit Up 69.6%

May 25, 2018 | Updated on May 25, 2018

For the quarter ended March 2018, NATCO PHARMA has posted a net profit of Rs 3 bn (up 69.6% YoY). Sales on the other hand came in at Rs 8 bn (up 32.9% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Should You Get out of Small Caps Now... Before the Fall Worsens(Profit Hunter)

Jun 6, 2018

An almost zero-loss strategy that works best when markets correct. Don't let the current volatility overwhelm you. Focus on the fundamentals and long term, and buy stocks where quality meets value.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA - SUVEN LIFE COMPARISON

COMPARE ELDER PHARMA WITH

MARKET STATS